Modification of interpretive breakpoints for netilmicin disk susceptibility tests with Pseudomonas aeruginosa
暂无分享,去创建一个
R. Jones | A. Barry | C. Thornsberry | R. Hare | G. Miller
[1] N. Legakis,et al. Survey of aminoglycoside resistance patterns. , 1986, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.
[2] L. Cone,et al. RANDOMISED, CONTROLLED TRIAL OF THE COMPARATIVE EFFICACY, AUDITORY TOXICITY, AND NEPHROTOXICITY OF TOBRAMYCIN AND NETILMICIN , 1983, The Lancet.
[3] R. Jones,et al. Azlocillin, a ureido penicillin active against Pseudomonas aeruginosa: interpretive zone standards and quality control parameters for tests with 75-mu g disks , 1982, Journal of clinical microbiology.
[4] R. Jones,et al. Cefsulodin: antibacterial activity and tentative interpretive zone standards for the disk susceptibility test , 1981, Antimicrobial Agents and Chemotherapy.
[5] R. Jones,et al. Gentamicin and amikacin disk susceptibility tests with Pseudomonas aeruginosa: definition of minimal inhibitory concentration correlates for susceptible and resistant categories , 1981, Journal of clinical microbiology.
[6] R. Jones,et al. Gentamicin, tobramycin, and sisomicin disc susceptibility tests. Revised zone standards for interpretation. , 1981, American journal of clinical pathology.
[7] R. Jones,et al. Tentative interpretive criteria for the diffusion susceptibility test using 30-microgram netilmicin disks , 1980, Antimicrobial Agents and Chemotherapy.
[8] E. Bruck,et al. National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.
[9] G. Mccracken,et al. Pharmacokinetic Properties of Netilmicin in Newborn Infants , 1979, Antimicrobial Agents and Chemotherapy.
[10] G. Goodhart,et al. Pharmacology and Efficacy of Netilmicin , 1978, Antimicrobial Agents and Chemotherapy.
[11] B. Meyers,et al. Pharmacokinetic Study of Netilmicin , 1977, Antimicrobial Agents and Chemotherapy.